Literature DB >> 15864079

The role of allergen avoidance in the secondary prevention of atopic disorders.

Angela Simpson1, Adnan Custovic.   

Abstract

PURPOSE OF REVIEW: Allergen avoidance is recommended as part of the treatment programme of many patients with allergic diseases in Europe and the USA. However, clinical trials of allergen avoidance tend to be small and the findings inconsistent. Several larger studies have recently been published, making a review of the new literature timely. RECENT
FINDINGS: There have been two large double-blind, placebo-controlled studies on the use of encasings (mattress, pillow and duvet) as a single intervention in adults with asthma. In both studies, participants in the active and the control group showed an improvement in peak flow, but there was no difference between groups over a 12-month period. A further smaller study of encasings reported an improvement in peak flow from 1 week in the active group; this study, however, was only of 9 weeks' duration. In children, the use of encasings was associated with a reduction in asthma medication usage, but not until 6 months into the study. A multifaceted intervention study, with the intervention tailored to the child's sensitization status and home environment (including environmental tobacco smoke), resulted in significant reductions in emergency room visits and symptoms in the active group.
SUMMARY: The evidence suggests that interventions in children (either single or multifaceted) are associated with a meaningful and sustained improvement in asthma control. However, for adults, allergen proof encasings as a single intervention cannot be recommended. There is a need for a large-scale multifaceted intervention study in adults with asthma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15864079     DOI: 10.1097/01.all.0000168785.51711.27

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  4 in total

1.  Environmental assessment and exposure control of dust mites: a practice parameter.

Authors:  Jay Portnoy; Jeffrey D Miller; P Brock Williams; Ginger L Chew; J David Miller; Fares Zaitoun; Wanda Phipatanakul; Kevin Kennedy; Charles Barnes; Carl Grimes; Désirée Larenas-Linnemann; James Sublett; David Bernstein; Joann Blessing-Moore; David Khan; David Lang; Richard Nicklas; John Oppenheimer; Christopher Randolph; Diane Schuller; Sheldon Spector; Stephen A Tilles; Dana Wallace
Journal:  Ann Allergy Asthma Immunol       Date:  2013-12       Impact factor: 6.347

Review 2.  Allergen avoidance.

Authors:  Euan R Tovey
Journal:  Curr Allergy Asthma Rep       Date:  2008-04       Impact factor: 4.806

3.  Requirements for acquiring a high-quality house dust mite extract for allergen immunotherapy.

Authors:  Franco Frati; Cristoforo Incorvaia; Marie David; Silvia Scurati; Simona Seta; Guglielmo Padua; Eleonora Cattaneo; Carlo Cavaliere; Alessia Di Rienzo; Ilaria Dell'Albani; Paola Puccinelli
Journal:  Drug Des Devel Ther       Date:  2012-05-18       Impact factor: 4.162

4.  Management of persistent allergic rhinitis: evidence-based treatment with levocetirizine.

Authors:  Joaquim Mullol; Claus Bachert; Jean Bousquet
Journal:  Ther Clin Risk Manag       Date:  2005-12       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.